«Tarsal Joints

Below is an extended Tarsal Joints patents listing. Click here to return to the Tarsal Joints main in depth entry.

Patents :
US Patent No.	Title
5248277	Method and device for processing the skin of a leg of a slaughtered bird
6219929	Apparatus for assessing and measuring foot and lower limb abnormalities
6448277	VEGF receptor tyrosine kinase inhibitors
6451314	MHC conjugates useful in ameliorating autoimmunity
6451562	Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
6488925	Macrophage inflammatory protein-4 (MIP-4) polypeptides
6623942	Macrophage inflammatory protein-4 (MIP-4) polynucleotides
6686347	Phthalazine derivatives for treating inflammatory diseases
6715219	Weighted footwear insert
6723747	Substituted 6H-DiBenzo[c,h]chromenes as estrogenic agents
6774248	Substituted 2-phenyl benzofurans as estrogenic agents
6177475	Methods of using integrin modulators for treatment of inflammation
6106840	MHC conjugates useful in ameliorating autoimmunity
6001606	Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
5260422	MHC conjugates useful in ameliorating autoimmunity
5334083	Method and device for mechanically drawing slaughtered poultry
5445603	Therapeutic ankle orthosis
5468481	MHC class II-peptide conjugates useful in ameliorating autoimmunity
5489742	Transgenic rats and animal models of inflammatory disease
5505657	Device for conveying slaughtered animals, in particular birds
5833535	Anterior tibialis exercise machine
5902259	Therapeutic ankle orthosis
5944678	Ankle brace
5981579	Use of nitrovasodilators for treatment of disease or stress conditions in a non-human mammal
6794403	Substituted benzoxazoles as estrogenic agents
6811773	Human monocyte colony inhibitory factor (M-CIF) polypeptides
7067543	Anthranilic acid amides and pharmaceutical use thereof
7091224	Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
7097647	Tarsal joint space distractor
7117034	Apparatus and method for bioelectric stimulation, healing acceleration, pain relief, or pathogen devitalization
7129258	Substituted benzoxazoles as estrogenic agents
7148247	Substituted benzoxazoles as estrogenic agents
7196318	Fiber-optic sensing system
7235539	6-Hydroxyequilenins as estrogenic agents
7294633	Oxazolo-and furopyrimidines and their use in medicaments against tumors
7329660	Phthalazine derivatives for treating inflammatory diseases
7067524	Substituted phenyl naphthalenes as estrogenic agents
7059954	Method and device for processing a poultry leg
7041460	Antibodies to monocyte-colony inhibitory factor (M-CIF)
6835745	Phenyl substituted thiophenes as estrogenic agents
6878720	VEGF receptor tyrosine kinase inhibitors
6884814	Phenyl benzisoxazoles as estrogenic agents
6903238	Substituted indenones as estrogenic agents
6911440	Phthalazine derivatives for treating inflammatory diseases
6914074	Substituted phenyl naphthalenes as estrogenic agents
6960607	Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
7002022	N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF
7004830	Method and device for processing poultry
7022733	Substituted 2-phenyl benzofurans as estrogenic agents
7364865	Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.